HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies

HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies

G-protein coupled receptor 119 (GPR119) has emerged as a novel target for the treatment of type 2 diabetes mellitus. GPR119 is involved in glucose-stimulated insulin secretion (GSIS) from the pancreatic β-cells and intestinal cells. In this study, we identified a novel small-molecule GPR119 agonist,...

Full description

Bibliographic Details
Main Authors: Kim, SoRa, Kim, Dae Hoon, Kim, Young-Seok, Ha, Tae-Young, Yang, Jin, Park, Soo Hyun, Jeong, Kwang Won, Rhee, Jae-Keol
Format: Online
Language:English
Published: The Korean Society of Applied Pharmacology 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201229/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201229/

Similar Items